Skip to main content
Home / Current Pharmaceutical Biotechnology, Volume 13, Number 3
Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 13, Number 3, 2012

Articles

Free Content Editorial [Hot Topic: Frontiers in Ovarian Stimulation (Guest Editor: Gian Mario Tiboni)]
pp. 378-378(1)
Author: Mario Tiboni, Gian

Favourites:
ADD

Present and Future of Recombinant Gonadotropins in Reproductive Medicine
pp. 379-391(13)
Authors: De Leo, Vincenzo; Concetta Musacchio, Maria; Di Sabatino, Alessandra; Tosti, Claudia; Morgante, Giuseppe; Petraglia, Felice

Favourites:
ADD

Ovarian Stimulation: Today and Tomorrow
pp. 392-397(6)
Authors: M. Fatemi, H.; Blockeel, C.; Devroey, P.

Favourites:
ADD

Possibilities and Limits of Ovarian Reserve Testing in ART
pp. 398-408(11)
Authors: La Marca, Antonio; Argento, Cindy; Sighinolfi, Giovanna; Grisendi, Valentina; Carbone, Marilena; D'Ippolito, Giovanni; Carducci Artenisio, Alfredo; Stabile, Gaspare; Volpe, Annibale

Favourites:
ADD

The Role of LH in Ovarian Stimulation
pp. 409-416(8)
Authors: Munoz, Elkin; Bosch, Ernesto; Fernandez, Iria; Portela, Susana; Ortiz, Ginna; Remohi, Jose; Pellicer, Antonio

Favourites:
ADD

Genetic Profile of SNP(s) and Ovulation Induction
pp. 417-425(9)
Authors: Loutradis, D.; Theofanakis, Ch; Anagnostou, E.; Mavrogianni, D.; A. Partsinevelos, G.

Favourites:
ADD

ESR1, ESR2 and FSH Receptor Gene Polymorphisms in Combination: A Useful Genetic Tool for the Prediction of Poor Responders
pp. 426-434(9)
Authors: Anagnostou, E.; Mavrogianni, D.; Theofanakis, Ch.; Drakakis, P.; Bletsa, R.; Demirol, A.; Gurgan, T.; Antsaklis, A.; Loutradis, D.

Favourites:
ADD

Modeling Follicle Stimulating Hormone Levels in Serum for Controlled Ovarian Hyperstimulation I: Comparing Gonadotropin Products
pp. 435-443(9)
Authors: H. McCulloh, David; Maseelall, Priya; M. Colon, Jose; G. McGovern, Peter

Favourites:
ADD

Modeling Follicle Stimulating Hormone (FSH) Levels in Serum for Controlled Ovarian Hyperstimulation II: The Underlying Mechanisms
pp. 444-453(10)
Authors: H. McCulloh, David; M. Colon, Jose; G. McGovern, Peter

Favourites:
ADD

Modeling Follicle Stimulating Hormone Levels in Serum for Controlled Ovarian Hyperstimulation III: Improved Gonadotropin Administration
pp. 454-463(10)
Authors: H. McCulloh, David; M. Colon, Jose; G. McGovern, Peter

Favourites:
ADD

Significantly Lower Pregnancy Rates in the Presence of Progesterone Elevation in Patients Treated with GnRH Antagonists and Gonadotrophins: A Systematic Review and Meta-Analysis
pp. 464-470(7)
Authors: M. Kolibianakis, E.; A. Venetis, C.; Bontis, J.; C. Tarlatzis, B.

Favourites:
ADD

Development of Stable Lyophilized Protein Drug Products
pp. 471-496(26)
Authors: L. Remmele, Richard; Krishnan, Sampathkumar; J. Callahan, William

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content